Amodiaquine Hydrochloride lands among the essential raw materials in the pharmaceutical world, especially for antimalarial formulations. With its chemical backbone firmly rooted in the group of 4-aminoquinoline derivatives, this compound tackles resistant strains of malaria where older medicines start to fail. The story of this substance stretches back to the clinical fight against Plasmodium falciparum, a major cause of severe and sometimes deadly malaria. For folks dealing directly with drug manufacture and formulation, the journey begins with powders and crystalline forms. Its presence on the bench or in the plant room always draws attention to safety, compliance, and the path it travels from manufacturer to medicine cabinet.
Bulk buyers, research chemists, and regulatory teams keep their eyes peeled for strict specifications. Looking at the product, the solid state arrives most often as yellowish crystalline powder or sometimes as dense flakes. This visible form reflects the stable structure of C20H23ClN3O·2HCl—the backbone of amodiaquine joined with two hydrochloride molecules. The HS Code guiding its trade and customs handling usually falls under 2933.49, which corresponds with other antimalarial pharmaceutical chemicals. In granular or powdery state, the material shows good solubility in water, thanks to the extra hydrochloride, making it suitable for both oral and parenteral formulations. From a storage perspective, the density and stability demand cool, dry conditions, where fluctuations in temperature or humidity might start to degrade the active component or encourage caking and decomposition. During my work with pharmaceutical intermediates, proper containment, and labeling matter just as much as purity in batches intended for GMP-regulated output.
Chemists appreciate the complexity built into every molecule of Amodiaquine Hydrochloride. The formula, C20H23ClN3O·2HCl, sketches out a backbone of 4-[(7-Chloro-4-quinolyl)amino]-2-[(diethylamino)methyl]phenol, where the aromatic core accepts two hydrochloride additions, boosting water solubility, and thus bioavailability. The molecular weight settles at 464.79 g/mol—numbers that drive batch preparation, dosing, and QA routines in every batch for researchers and production teams. From the crystalline matrix formed during synthesis, analytical teams frequently employ HPLC and IR spectroscopy to verify purity and identity, ensuring no foreign substances slip through the net.
Amodiaquine Hydrochloride appears most often as a yellow crystalline powder. It holds a specific density in the range of 1.2-1.4 g/cm³, based on measurement traditions from lab scales to industrial containers. Physically, this compound tends to remain stable, though moisture content, light exposure, and temperature swings can compromise its integrity. The melting point hovers between 166°C and 172°C, and the substance doesn’t turn into pearls or high-viscosity liquids under standard storage conditions—it remains steadfastly solid. Its solubility in water ranks as high, aligning with its hydrochloride classification, while solubility drops off in non-polar organic solvents. In manufacturing, recognizing the powdery versus flaked material can help prevent processing challenges, whether preparing a batch for tableting or for a solubilized oral suspension.
Like many raw materials in the pharmaceutical supply chain, Amodiaquine Hydrochloride calls for clear, careful handling. Though crucial as a medicine, it also has potential hazards tied to toxicity and handling requirements. Workers must use gloves, goggles, and appropriate face masks during weighing and transfer processes. Dust generation, accidental spills, or contact with bare skin can pose health risks, especially for workers directly exposed during extended shifts. It’s not just the packaging or batch records that matter—clear demarcations in storage, separation from food and other incompatible substances, and secure, labeled shelves make a difference every single day. The bulk powder, being classified under hazardous chemicals, must travel with safety data sheets and comply with both international freight regulations and in-house safety drills.
Through years working in manufacture supporting disease control programs, I’ve learned how Amodiaquine Hydrochloride stands apart for its role against drug-resistant malaria. This isn’t just about formulation; governments and NGOs rely on steady, quality supply to form the base for combination therapies that work far better than single drugs. Strict regulator scrutiny and precise documentation not only protect the public but also support trust in medicines that arrive in field hospitals and village clinics. The fact that Amodiaquine Hydrochloride’s status as a WHO Model List essential medicine highlights its impact, stretching from raw chemical to finished tablet packed in foil.
Recent years bring challenges with counterfeiting, substandard batches, and unstable supply chains. This is more than a supplier problem—it becomes a systemic risk when bad batches slip through weak regulatory gates. To reduce these risks, traceable batch records, barcoding, and independent lab validation matter just as much as trusted suppliers. Stronger customs enforcement using HS Codes and real-time monitoring can close major loopholes in international trafficking of fake or diluted ingredients. Back at the plant, investing in real analytical equipment, not just paperwork, pays off for the bottom line and downstream patient safety. Training front-line staff in proper PPE use and safe chemical handling brings down accident rates, improves morale, and makes for a steadier operation.
| Property | Description |
|---|---|
| Chemical Name | Amodiaquine Hydrochloride |
| Molecular Formula | C20H23ClN3O·2HCl |
| Molecular Weight | 464.79 g/mol |
| HS Code | 2933.49 |
| Physical Form | Yellow crystalline powder or flakes |
| Density | 1.2-1.4 g/cm³ |
| Solubility | Highly soluble in water |
| Melting Point | 166-172°C |
| Hazardous | Yes (skin, eye, respiratory hazard) |
| Storage | Cool, dry, well-ventilated space |